📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis. (2019)

First Author: Purchase SE

Attributed to: Correlates of risk in children exposed to multidrug-resistant tuberculosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/inf.0000000000002268

PubMed Identifier: 30550511

Publication URI: http://europepmc.org/abstract/MED/30550511

Type: Journal Article/Review

Volume: 38

Parent Publication: The Pediatric infectious disease journal

Issue: 6

ISSN: 0891-3668